Theriva Biologics, Inc. Right-of-Use Asset Obtained in Exchange for Operating Lease Liability
Theriva Biologics, Inc. (TOVX) reported Right-of-Use Asset Obtained in Exchange for Operating Lease Liability of $937.00 thousand for the 9-month period ending 2025-09-30, per its 10-Q filed 2025-11-12.
Financial Statements › Notes › Leases
us-gaap:RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability · last filed 2025-11-12
- Theriva Biologics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-09-30 was $0.00.
- Theriva Biologics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-06-30 was $0.00.
- Theriva Biologics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2025-03-31 was $937.00K, a 0.00% change year-over-year.
- Theriva Biologics, Inc. right-of-use asset obtained in exchange for operating lease liability for the quarter ending 2024-12-31 was -$937.00K.
- Theriva Biologics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- Theriva Biologics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2023 was $937.00K.
- Theriva Biologics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2022 was $0.00, a 100.00% decline from fiscal 2021.
- Theriva Biologics, Inc. right-of-use asset obtained in exchange for operating lease liability for fiscal 2021 was $1.27M.
| Period end | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 3 month as first filed | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 6 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 9 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-12 | $0.00 derived: sum of 2 quarters · filed 2025-11-12 | $937.00K 10-Q · filed 2025-11-12 | $0.00 derived: sum of 4 quarters · filed 2025-11-12 | ||
| 2025-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-11 | $937.00K 10-Q · filed 2025-08-11 | $0.00 derived: sum of 3 quarters · filed 2025-08-11 | $0.00 derived: sum of 4 quarters · filed 2025-08-11 | ||
| 2025-03-31 | $937.00K 10-Q · filed 2025-05-14 | $0.00 derived: sum of 2 quarters · filed 2025-05-14 | $0.00 derived: sum of 3 quarters · filed 2025-05-14 | $0.00 derived: sum of 4 quarters · filed 2025-05-14 | ||
| 2024-12-31 | -$937.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | -$937.00K derived: sum of 2 quarters · filed 2025-03-06 | -$937.00K derived: sum of 3 quarters · filed 2025-03-06 | $0.00 10-K · filed 2025-03-06 | ||
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $937.00K 10-Q · filed 2024-11-12 | $937.00K derived: sum of 4 quarters · filed 2025-03-06 | ||
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $937.00K 10-Q · filed 2024-08-13 | $937.00K derived: sum of 3 quarters · filed 2025-03-06 | $937.00K derived: sum of 4 quarters · filed 2025-03-06 | ||
| 2024-03-31 | $937.00K 10-Q · filed 2024-05-07 | $937.00K derived: sum of 2 quarters · filed 2025-03-06 | $937.00K derived: sum of 3 quarters · filed 2025-03-06 | $937.00K derived: sum of 4 quarters · filed 2025-03-06 | ||
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-06 | $0.00 derived: sum of 2 quarters · filed 2025-03-06 | $0.00 derived: sum of 3 quarters · filed 2025-03-06 | $937.00K 10-K · filed 2025-03-06 | ||
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | $0.00 derived: sum of 2 quarters · filed 2024-11-12 | $937.00K 10-Q · filed 2024-11-12 | $937.00K derived: sum of 4 quarters · filed 2024-11-12 | ||
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | $937.00K 10-Q · filed 2024-08-13 | $937.00K derived: sum of 3 quarters · filed 2024-08-13 | $937.00K derived: sum of 4 quarters · filed 2024-08-13 | ||
| 2023-03-31 | $937.00K 10-Q · filed 2024-05-07 | $937.00K derived: sum of 2 quarters · filed 2024-05-07 | $937.00K derived: sum of 3 quarters · filed 2024-05-07 | $937.00K derived: sum of 4 quarters · filed 2024-05-07 | ||
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-25 | $0.00 derived: sum of 2 quarters · filed 2024-03-25 | $0.00 derived: sum of 3 quarters · filed 2024-03-25 | $0.00 10-K · filed 2024-03-25 | ||
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $0.00 derived: sum of 2 quarters · filed 2022-11-10 | $0.00 10-Q · filed 2022-11-10 | $0.00 derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $0.00 10-Q · filed 2022-08-11 | $0.00 derived: sum of 3 quarters · filed 2023-05-11 | $0.00 derived: sum of 4 quarters · filed 2023-05-11 | ||
| 2022-03-31 | $0.00 10-Q · filed 2023-05-11 | $1.30M 10-Q · filed 2022-05-16 | $0.00 derived: sum of 2 quarters · filed 2023-05-11 | $0.00 derived: sum of 3 quarters · filed 2023-05-11 | $1.27M derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | $0.00 derived: sum of 2 quarters · filed 2023-03-30 | $1.27M derived: sum of 3 quarters · filed 2023-03-30 | $1.27M 10-K · filed 2023-03-30 | ||
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-10 | $1.27M derived: sum of 2 quarters · filed 2022-11-10 | $1.27M 10-Q · filed 2022-11-10 | $1.27M derived: sum of 4 quarters · filed 2022-11-10 | ||
| 2021-06-30 | $1.27M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $1.27M 10-Q · filed 2022-08-11 | $1.27M derived: sum of 3 quarters · filed 2022-08-11 | $1.27M derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $0.00 10-Q · filed 2021-05-05 | $0.00 derived: sum of 2 quarters · filed 2022-03-16 | $0.00 derived: sum of 3 quarters · filed 2022-03-16 | $0.00 derived: sum of 4 quarters · filed 2022-03-16 | ||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-16 | $0.00 derived: sum of 2 quarters · filed 2022-03-16 | $0.00 derived: sum of 3 quarters · filed 2022-03-16 | $0.00 10-K · filed 2022-03-16 | ||
| 2020-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-03 | $0.00 derived: sum of 2 quarters · filed 2021-11-03 | $0.00 10-Q · filed 2021-11-03 | -$1.00K derived: sum of 4 quarters · filed 2021-11-03 | ||
| 2020-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-05 | $0.00 10-Q · filed 2021-08-05 | -$1.00K derived: sum of 3 quarters · filed 2021-08-05 | -$1.00K derived: sum of 4 quarters · filed 2021-08-05 | ||
| 2020-03-31 | $0.00 10-Q · filed 2020-05-05 | -$1.00K derived: sum of 2 quarters · filed 2021-03-04 | -$1.00K derived: sum of 3 quarters · filed 2021-03-04 | -$1.00K derived: sum of 4 quarters · filed 2021-03-04 | ||
| 2019-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04 | -$1.00K derived: sum of 2 quarters · filed 2021-03-04 | -$1.00K derived: sum of 3 quarters · filed 2021-03-04 | $537.00K 10-K · filed 2021-03-04 | $0.00 10-Q · filed 2019-11-04 | |
| 2019-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-10 | $0.00 derived: sum of 2 quarters · filed 2020-11-10 | $538.00K 10-Q · filed 2020-11-10 | $538.00K derived: sum of 4 quarters · filed 2020-11-10 | ||
| 2019-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-06 | $538.00K 10-Q · filed 2020-08-06 | $538.00K derived: sum of 3 quarters · filed 2020-08-06 | |||
| 2019-03-31 | $538.00K 10-Q · filed 2020-05-05 | $0.00 10-Q · filed 2019-05-08 | $538.00K derived: sum of 2 quarters · filed 2020-05-05 | |||
| 2018-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-20 | $0.00 10-K · filed 2020-02-20 | ||||
| 2018-09-30 | $0.00 10-Q · filed 2019-11-04 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |